India Share Brokers | Equity Trading India | Derivative Trading in India | Share Brokers in India

Markets Navigation

Company Info.

Alivus Life Sciences Ltd.

Balance Sheet - Standalone

Market Cap.(`)	13668.69 Cr.	P/BV	5.38	Book Value (`)	207.17
52 Week High/Low ( ` )	1335/677	FV/ML	2/1	P/E(X)	29.03
Book Closure	17/10/2023	EPS (`)	38.43	Div Yield (%)	0.00

(` in Crs.)

You can view the Standalone Balance Sheet for the last 5 years.

Particulars	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	2.00	2.00	2.00	2.00	10.00
No. of Equity Shares (in Lacs)	1225.27	1225.27	1225.27	98.00	19.60

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	24.51	24.51	24.51	1.96	1.96
Total Share Capital	24.51	24.51	24.51	1.96	1.96

Reserves and Surplus	2307.82	2107.02	2026.31	750.79	399.73
Total Reserves and Surplus	2307.82	2107.02	2026.31	750.79	399.73
Employees Stock Options	0.00	6.68	3.50	0.00	0.00
Total Shareholders Funds	2332.32	2138.21	2054.31	752.75	401.69

NON-CURRENT LIABILITIES
Deferred Tax Liabilities [Net]	48.79	42.43	31.50	22.89	16.45
Other Long Term Liabilities	14.76	17.09	1.20	0.00	0.00
Long Term Provisions	15.77	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	79.32	59.53	32.70	22.89	16.45

CURRENT LIABILITIES
Short Term Borrowings	0.00	0.00	0.00	0.00	0.02
Trade Payables	368.66	396.56	307.72	221.31	201.07
Other Current Liabilities	58.08	92.32	61.84	980.23	1092.39
Short Term Provisions	12.03	15.54	14.44	19.90	13.98
Total Current Liabilities	438.77	504.41	384.00	1221.44	1307.46

Total Capital And Liabilities	2850.41	2702.15	2471.01	1997.08	1725.60

ASSETS
NON-CURRENT ASSETS
Tangible Assets	795.01	774.89	584.65	564.89	539.08
Intangible Assets	10.05	5.74	10.38	7.91	7.17
Capital Work-In-Progress	101.19	49.35	91.69	14.10	10.73
Intangible Assets Under Development	4.80	12.26	0.00	0.00	0.00
Fixed Assets	911.05	842.25	686.72	586.90	556.98
Non-Current Investments	0.08	0.08	0.08	0.08	0.08
Other Non-Current Assets	23.29	9.49	19.63	11.06	8.44
Total Non-Current Assets	934.41	851.81	706.42	598.03	565.49


CURRENT ASSETS
Inventories	666.59	604.17	516.24	513.42	412.78
Trade Receivables	765.43	806.77	673.49	619.50	638.63
Cash And Cash Equivalents	301.59	309.40	512.16	115.60	10.00
OtherCurrentAssets	182.38	130.01	62.69	150.52	98.71
Total Current Assets	1916.00	1850.34	1764.58	1399.04	1160.11

Total Assets	2850.41	2702.15	2471.01	1997.08	1725.60

OTHER INFORMATION

CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	34.20	12.83	50.42	17.23	38.93

BONUS DETAILS
Bonus Equity Share Capital	19.60	19.60	19.60	0.00	0.00

NON-CURRENT INVESTMENTS
Non-Current Investments Unquoted Book Value	0.08	0.08	0.08	0.08	0.08

Alivus Life Sciences Ltd.

Ratio Analysis - Standalone

Market Cap.(`)	13668.69 Cr.	P/BV	5.38	Book Value (`)	207.17
52 Week High/Low ( ` )	1335/677	FV/ML	2/1	P/E(X)	29.03
Book Closure	17/10/2023	EPS (`)	38.43	Div Yield (%)	0.00

You can view the Standalone Ratio Analysis for the last 5 years.

Particulars	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	2.00	2.00	2.00	2.00	10.00

PER SHARE RATIOS

Basic EPS (Rs.)	38.43	38.11	35.63	32.61	1597.37
Diluted EPS (Rs.)	38.38	38.11	35.63	32.61	1597.37
Cash EPS (Rs.)	42.79	41.55	37.27	392.83	1747.28
Book Value[Excl.RevalReserv]/Share (Rs.)	190.35	174.51	167.66	768.11	2049.45
Book Value[Incl.RevalReserv]/Share (Rs.)	190.35	174.51	167.66	768.11	2049.45
Dividend / Share (Rs.)	22.50	21.00	21.00	0.00	0.00
Revenue From Operations / Share (Rs.)	186.35	176.39	173.29	1923.64	7843.43
PBDIT / Share (Rs.)	56.01	54.78	51.48	603.96	2469.13
PBIT / Share (Rs.)	51.65	51.35	48.39	569.89	2319.30
PBT / Share (Rs.)	51.52	51.30	46.11	480.56	2148.30
Net Profit / Share (Rs.)	38.43	38.11	34.17	358.76	1597.44

PROFITABILITY RATIOS

PBDIT Margin (%)	30.05	31.05	29.70	31.39	31.48
PBIT Margin (%)	27.71	29.11	27.92	29.62	29.56
PBT Margin (%)	27.64	29.08	26.60	24.98	27.38
Net Profit Margin (%)	20.62	21.60	19.72	18.64	20.36
Return on Networth / Equity (%)	20.18	21.83	20.38	46.70	77.94
Return on Capital Employeed (%)	26.24	28.62	28.40	72.00	108.71
Return On Assets (%)	16.51	17.28	16.94	17.60	18.14
Asset Turnover Ratio (%)	0.82	0.83	0.95	1.01	0.96

LIQUIDITY RATIOS

Current Ratio (X)	4.37	3.67	4.60	1.15	0.88
Quick Ratio (X)	2.85	2.47	3.25	0.72	0.57
Inventory Turnover Ratio (X)	1.67	1.96	1.95	2.11	1.71
Dividend Payout Ratio (NP) (%)	58.54	82.65	30.72	0.00	0.00
Dividend Payout Ratio (CP) (%)	52.57	75.81	28.17	0.00	0.00
Earning Retention Ratio (%)	41.46	17.35	69.28	0.00	0.00
Cash Earning Retention Ratio (%)	47.43	24.19	71.83	0.00	0.00

COVERAGE RATIOS

Interest Coverage Ratio (%)	443.91	1227.15	22.56	6.76	14.44
Interest Coverage Ratio (Post Tax) (%)	305.58	854.68	15.97	5.02	10.34

VALUATION RATIOS

Enterprise Value (Cr.)	9197.77	4488.68	5111.73	0.00	0.00
EV / Net Operating Revenue (X)	4.03	2.08	2.41	0.00	0.00
EV / EBITDA (X)	13.40	6.69	8.10	0.00	0.00
MarketCap / Net Operating Revenue (X)	4.16	2.22	2.65	0.00	0.00
Retention Ratios (%)	41.45	17.34	69.27	0.00	0.00
Price / BV (X)	4.07	2.24	2.74	0.00	0.00
Price / Net Operating Revenue (X)	4.16	2.22	2.65	0.00	0.00
EarningsYield	0.04	0.09	0.07	0.00	0.00

Attention Investors : “Prevent unauthorized transactions in your account ? Update your Mobile Numbers/Email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your Mobile/Email at the end of the day. Issued in the interest of Investors” ***** No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. | | ***** KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary. | "Revised guidelines on margin collection ==> 1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. | 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. | 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. | 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. | 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. .......... Issued in the interest of Investors" | ***** MEMBERS : SEBI Regn. No: NSE, BSE: INZ000176636 ; MCX : INZ000057535; SEBI Research Analyst Regn No: INH200000337; AMFI Regn No. 77624; Depository Participant : CDSL : IN-DP-CDSL-379-2006 DP ID : 12047600 | For any Grievance mail to : grievance@sharewealthindia.com | For any DP Grievance mail to : dpgrievance@sharewealthindia.com. | Grievance with SEBI : https://scores.gov.in/scores/Welcome.html

Share Wealth

Alivus Life Sciences Ltd.

Balance Sheet - Standalone

Alivus Life Sciences Ltd.

Ratio Analysis - Standalone